Literature DB >> 3143807

Attachment of mycobacteria to fibronectin-coated surfaces.

T L Ratliff1, J A McGarr, C Abou-Zeid, G A Rook, J L Stanford, J Aslanzadeh, E J Brown.   

Abstract

This report investigates the extent of the expression of fibronectin (FN) binding properties among the mycobacteria and provides preliminary characteristics of the bacterial molecule(s) mediating attachment. Eight BCG substrains, three Mycobacterium tuberculosis strains and four other mycobacterial species all expressed FN-binding capacity. Treatment of organisms with detergent prior to the binding assay destroyed the FN-binding capacity of BCG but not that of Staphylococcus aureus. Trypsin pretreatment eliminated the FN-binding capacity of both BCG and S. aureus. [35S]Methionine-labelled material in supernatants from BCG and M. tuberculosis cultures attached to FN-coated surfaces. These culture supernatants inhibited the attachment of BCG but not S. aureus to FN-coated surfaces. This inhibitory activity of the supernatants was removed by affinity chromatography on FN-Sepharose but was not affected by similar passage over a control column (human serum albumin attached to Sepharose). These results demonstrate that the ability to bind FN is present in all mycobacterial species tested and suggest that attachment is mediated by trypsin-sensitive cell-surface component(s).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3143807     DOI: 10.1099/00221287-134-5-1307

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  25 in total

1.  Fish rhabdovirus cell entry is mediated by fibronectin.

Authors:  M Bearzotti; B Delmas; A Lamoureux; A M Loustau; S Chilmonczyk; M Bremont
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Serological response of patients with leprosy to a 28- to 30-kilodalton protein doublet from early cultures of Mycobacterium bovis BCG.

Authors:  M C Pessolani; F D Rumjanek; M A Marques; F S de Melo; E N Sarno
Journal:  J Clin Microbiol       Date:  1989-10       Impact factor: 5.948

3.  Disruption of the genes encoding antigen 85A and antigen 85B of Mycobacterium tuberculosis H37Rv: effect on growth in culture and in macrophages.

Authors:  L Y Armitige; C Jagannath; A R Wanger; S J Norris
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Evidence for three separate genes encoding the proteins of the mycobacterial antigen 85 complex.

Authors:  H G Wiker; K Sletten; S Nagai; M Harboe
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

5.  Activation of complement receptor 3 on human monocytes by cross-linking of very-late antigen-5 is mediated via protein tyrosine kinases.

Authors:  B M van den Berg; R van Furth; W L Hazenbos
Journal:  Immunology       Date:  1999-10       Impact factor: 7.397

6.  Cloning and sequencing of the gene for alpha antigen from Mycobacterium avium and mapping of B-cell epitopes.

Authors:  N Ohara; K Matsuo; R Yamaguchi; A Yamazaki; H Tasaka; T Yamada
Journal:  Infect Immun       Date:  1993-04       Impact factor: 3.441

7.  Mechanism of interaction of the 85B secreted protein of Mycobacterium bovis with fibronectin.

Authors:  P Peake; A Gooley; W J Britton
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

8.  Serology and leprosy: immunoassays comparing immunoglobulin G antibody responses to 28- and 30-kilodalton proteins purified from Mycobacterium bovis BCG.

Authors:  M C Pessolani; J M Peralta; F D Rumjanek; H M Gomes; M A Marques; E C Almeida; M H Saad; E N Sarno
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

9.  Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets.

Authors:  J Coburn; J M Leong; J K Erban
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

10.  Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding proteins.

Authors:  H P Godfrey; Z Feng; S Mandy; K Mandy; K Huygen; J De Bruyn; C Abou-Zeid; H G Wiker; S Nagai; H Tasaka
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.